In the intention-to-treat population , 110 ( 866 % ) of 127 patients in the triple-treatment group responded to treatment versus 108 ( 878 % ) of 123 in the dual-treatment group ( difference -12 % [ 95 % CI -96 to 73 ] ; p = 092 ) , meeting the criteria for non-inferiority .